No Picture
News

Lineage Cell Therapeutics to Present at 2019 Cantor Global Healthcare Conference on October 4, 2019

CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #AMD–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, announced today that Brandi L. Roberts, Ch… […]

No Picture
News

ACADIA Pharmaceuticals to Present at the 2019 Cantor Global Healthcare Conference on October 2, 2019

SAN DIEGO–(BUSINESS WIRE)–ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in central nervous system disorders, today ann… […]

No Picture
News

CeleCor Therapeutics Announces Positive First-in-Human Data of RUC-4, a Novel Subcutaneous Platelet GPIIb/IIIa Inhibitor, Presented at TCT 2019

SAN DIEGO–(BUSINESS WIRE)– #TCT2019–FIH data shows that RUC-4, a novel subcutaneous platelet GPIIb/IIIa inhibitor, resulted in a potent, rapid, and sustained platelet inhibition effect. […]